GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dual glucose insulinotropic polypeptide (GIP)/GLP-1 RA are widely prescribed, but their effectiveness in different subtypes of maturity-onset diabetes of the young (MODY) is unknown.Research design and methods We present a descrip...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2025-04-01
|
| Reeks: | BMJ Open Diabetes Research & Care |
| Online toegang: | https://drc.bmj.com/content/13/2/e004885.full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|